3Weir MR,Rolfe M.Potassium homeostasis and Renin-Angiotensinaldosterone system inhibitors[J].Clin J Am Soc Nephrol,2010,5(3):531-548.
4Pernelle N,Haleh B.Life-threatening drug-associated hyperkalemia:a retrospective study from laboratory signals[J].Pharmacoepidemiol Drug Saf,2011,20(7):747-753.
5Tzamaloukas AH, Avasthi PS. Temporal profile of serllnl potas- sium concentration in nondiabetic and diabetic outpa tients on chronic dialysis[J]. Am J Nephrol,1987,7:101-109.
6Salem M, Batlle D. Hyperkalemia and hypokalemia[EB/OL]. [2009 -- 02 -- 01][J]. http://merck, micromedex, eom/index. P. 258.
7Morduehowicz G,Winkler J, Derazne E, et al. Cause ofdeathin pa tients with end--stage renal disease treated by dialysis in a cen- ter in Israel[J]. lsr J Med Sci,1992,28:776--779.
8National kidney foundation dialysis outcomes quality initiative, NKF--K/DOQI clinical practice guidelines for peritoneal dialy- sis adequacy: Update 2000[J]. Am J Kidney Dis, 2000,135-- 136.
9Carlos G. Musso. Potassium metabolism in patients with chronic kidney disease. Part II: Patients on dialysis (stage 5)[J] 2004,International Urology and Nephrology(3):469～472
